BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36855972)

  • 1. Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study.
    Alito A; Basile GC; Bruschetta D; Berescu GL; Cavallaro F; Postorino AD; Scarcella E; Ragonese M; Cannavò S; Tisano A
    Folia Med (Plovdiv); 2023 Feb; 65(1):37-45. PubMed ID: 36855972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
    Caron PJ; Bevan JS; Petersenn S; Houchard A; Sert C; Webb SM;
    Pituitary; 2016 Apr; 19(2):149-57. PubMed ID: 26603536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.
    Fatti LM; Cangiano B; Vitale G; Persani L; Mantovani G; Sala E; Arosio M; Maffei P; Dassie F; Mormando M; Giampietro A; Tanda L; Masiello ER; Nazzari E; Ferone D; Corbetta S; Passeri E; Guaraldi F; Grottoli S; Cannavò S; Torre MLT; Soranna D; Zambon A; Cavagnini F; Scacchi M;
    Pituitary; 2019 Oct; 22(5):552-560. PubMed ID: 31032537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between paraclinical parameters, symptoms and quality of life in patients with acromegaly: a cross sectional study.
    Gliga MC; Reti Z; Gliga C; Pascanu IM
    J Patient Rep Outcomes; 2022 Dec; 6(1):130. PubMed ID: 36577870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
    Chin SO; Chung CH; Chung YS; Kim BJ; Kim HY; Kim IJ; Kim JG; Kim MS; Kim SY; Lee EJ; Lee KY; Kim SW
    BMJ Open; 2015 Jun; 5(6):e006898. PubMed ID: 26063564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology.
    Cellini M; Biamonte E; Mazza M; Trenti N; Ragucci P; Milani D; Ferrante E; Rossini Z; Lavezzi E; Sala E; Mantovani G; Arosio M; Fornari M; Balzarini L; Lania AG; Mazziotti G
    Neuroendocrinology; 2021; 111(8):775-785. PubMed ID: 32980840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
    Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties.
    Webb SM; Prieto L; Badia X; Albareda M; Catalá M; Gaztambide S; Lucas T; Páramo C; Picó A; Lucas A; Halperin I; Obiols G; Astorga R
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):251-8. PubMed ID: 12153605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life.
    Cangiano B; Giusti E; Premoli C; Soranna D; Vitale G; Grottoli S; Cambria V; Mantovani G; Mungari R; Maffei P; Dassie F; Giampietro A; Chiloiro S; Tanda ML; Ippolito S; Cannavò S; Ragonese M; Zambon A; Persani L; Fatti LM; Scacchi M;
    Endocrine; 2022 Sep; 77(3):510-518. PubMed ID: 35779206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
    Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.
    Yoshida K; Fukuoka H; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Ogawa W; Webb SM; Takahashi Y
    Pituitary; 2015 Dec; 18(6):876-83. PubMed ID: 26123761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly Quality of Life Questionnaire (AcroQoL).
    Badia X; Webb SM; Prieto L; Lara N
    Health Qual Life Outcomes; 2004 Feb; 2():13. PubMed ID: 14987332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.
    Neggers SJ; van Aken MO; de Herder WW; Feelders RA; Janssen JA; Badia X; Webb SM; van der Lely AJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3853-9. PubMed ID: 18647806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
    Salvatori R; Maffei P; Webb SM; Brue T; Loftus J; Valluri SR; Gomez R; Wajnrajch MP; Fleseriu M
    Pituitary; 2022 Jun; 25(3):420-432. PubMed ID: 35022929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis.
    Broersen LHA; Zamanipoor Najafabadi AH; Pereira AM; Dekkers OM; van Furth WR; Biermasz NR
    J Clin Endocrinol Metab; 2021 Jan; 106(2):577-587. PubMed ID: 33245343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and quality of life responses to octreotide-LAR in acromegaly.
    Mangupli R; Camperos P; Webb SM
    Pituitary; 2014 Dec; 17(6):495-9. PubMed ID: 24178448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.